FX.co ★ Prenetics Global Q3 Loss Narrows On Surge In Revenue

Prenetics Global Ltd. (PRE) reported a reduced loss for the third quarter, accompanied by a notable 59.4% increase in revenue compared to the previous year. The health sciences company recorded a quarterly loss of $12.06 million, an improvement from the $14.08 million loss reported in the same period last year. On a per-share basis, this translates to a loss of $0.84, slightly better than the $0.88 per share loss from the previous year. Revenue for the quarter rose to $7.78 million, up from $4.88 million in the prior year. Additionally, Prenetics reaffirmed its goal to surpass $33 million in revenue for the full year 2024.